CMG Pharmaceutical Co. Ltd (058820) — Tangible Net Worth Ratio
CMG Pharmaceutical Co. Ltd (058820) has a Tangible Net Worth Ratio of 92.0% as of December 2025. This metric is calculated by deducting intangible assets (₩16.20 Billion) from net assets (₩201.55 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See CMG Pharmaceutical Co. Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
CMG Pharmaceutical Co. Ltd Tangible Net Worth Ratio (2011–2025)
This chart shows how CMG Pharmaceutical Co. Ltd's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 92.0%, reflecting net assets of ₩201.55 Billion with intangible assets of ₩16.20 Billion KRW. See CMG Pharmaceutical Co. Ltd (058820) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for CMG Pharmaceutical Co. Ltd (2011–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for CMG Pharmaceutical Co. Ltd from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 058820 market cap.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | ₩201.55 Billion | ₩16.20 Billion | ₩305.96 Billion | ▲ +2.1 pp |
| 2024 | 89.8% | ₩189.54 Billion | ₩19.28 Billion | ₩303.44 Billion | ▼ -1.1 pp |
| 2023 | 90.9% | ₩190.23 Billion | ₩17.30 Billion | ₩242.10 Billion | ▼ -1.3 pp |
| 2022 | 92.2% | ₩184.95 Billion | ₩14.39 Billion | ₩213.26 Billion | ▼ -0.9 pp |
| 2021 | 93.1% | ₩184.70 Billion | ₩12.71 Billion | ₩199.17 Billion | ▼ -0.2 pp |
| 2020 | 93.3% | ₩181.13 Billion | ₩12.06 Billion | ₩195.36 Billion | ▼ -0.5 pp |
| 2019 | 93.9% | ₩180.16 Billion | ₩11.08 Billion | ₩192.24 Billion | ▲ +1.6 pp |
| 2018 | 92.2% | ₩103.98 Billion | ₩8.07 Billion | ₩114.38 Billion | ▼ 0.0 pp |
| 2017 | 92.2% | ₩97.94 Billion | ₩7.60 Billion | ₩109.57 Billion | ▲ +5.6 pp |
| 2016 | 86.6% | ₩101.11 Billion | ₩13.55 Billion | ₩110.98 Billion | ▲ +11.7 pp |
| 2015 | 74.9% | ₩46.81 Billion | ₩11.77 Billion | ₩56.53 Billion | ▼ -23.5 pp |
| 2014 | 98.4% | ₩49.00 Billion | ₩793.13 Million | ₩58.07 Billion | ▼ -0.9 pp |
| 2013 | 99.3% | ₩49.00 Billion | ₩363.09 Million | ₩55.91 Billion | ▼ -0.3 pp |
| 2012 | 99.5% | ₩31.59 Billion | ₩154.90 Million | ₩57.11 Billion | ▲ +7.3 pp |
| 2011 | 92.2% | ₩18.03 Billion | ₩1.40 Billion | ₩27.31 Billion | — |